Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees

Journal of Occupational and Environmental Medicine

Volumn 41, Issue 9, 1999, Pages 799-806

  Olsen, Geary W ^a   Burris, Jean M ^a   Mandel, Jeffrey H ^a   Zobel, Larry R ^a  

^a 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; FLUORIDE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; PERFLUOROOCTANE; SULFONIC ACID DERIVATIVE; TRIACYLGLYCEROL;

ARTICLE; CLINICAL CHEMISTRY; EMPLOYEE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOLIPEMIA; LIVER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; SERUM;

EID: 0032886380     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199909000-00012     Document Type: Article

References (25)

1. 14C In Feed. St. Paul, MN: Riker Laboratories Inc; 1983.
2. 14 C. Project No. 8900310200. St. Paul, MN: Riker Laboratories Inc; 1979.
3. 14C] perfluorooctanesulfonate. Fund Appl Toxicol. 1984;4:972-976.
4. Goldenthal EI, Jessup DC, Geil RG, Jefferson ND, Arceo RJ. Ninety-Day Subacute Rat Toxicity Study. Study No. 137-085. Mattawan, MI: International Research Development Corp; November 1978.
5. Goldenthal EI, Jessup DC, Geil RG, Jefferson ND. Ninety-Day Subacute Rhesus Monkey Toxicity Study. Study No 137-085. Mattawan, MI: International Research Development Corp; December 1978.
6. Goldenthal EI, Jessup DC, Geil RG, Jefferson ND. Ninety-Day Subacute Rhesus Monkey Toxicity Study. Study No. 137-087. Mattawan, MI: International Research Development Corp; January 1979.
7. Thomford PJ. Four-Week Capsule Toxicity Study With Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) in Cynomologus Monkeys. Covance Study 6329-222. Madison, WI: Covance Co; August 1998.
8. Ikeda T, Fukuda K, Mori I, Enomoto M, Komai T, Suga T. Induction of cytochrome P-450 and peroxisome proliferation in rat liver by perfluorinated octanesulfonic acid. In: Fahimi HD, Sies H, eds. Peroxisomes in Biology and Medicine. New York: Springer Verlag; 1987:304-308.
9. Haughom B, Spydevold O. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluoroctane sulphonic acid (PFOSA) and clofibric acid. Biochem Biophys Acta. 1992;1128:65-72.
10. Sohlenius AK, Eriksson AM, Hogstrom C, Kimland M, DePierre JW. Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver. Pharmacol Toxicol. 1993;72:90-93.
11. Nabbefeld J, Butenhoff, J, Bass N, Seacat A. Displacement of a fluorescently labeled fatty acid analogue from fatty acid carrier proteins by Wyeth-14,643, ammonium perfluorooctanoate, potassium perfluorooctane sulfonate and other known peroxisome proliferators (abstract). Toxicologist. 1998;42:395.
12. Bryce H. Industrial and utilitarian aspects of fluorine chemistry. In: Simons J, ed. Fluorine Chemistry. New York: Academic Press; 1964:297-492.
13. Johnson JD, Wolter JT, Colaizy GE, Rethwill PA, Nelson RM. Quantification of Perflurooctanoate and Perfluorooctanesulfonate in Human Serum Using Ion-Pair Extraction and High Performance Liquid Chromatography-Thermospray Mass Spectrometry With Automated Sample Preparation. St. Paul, MN: 3M Environmental Laboratory; 1996.
14. Anderson DJ, Mulvana DE. Analytical Report for the Determination of Perfluorooctanoate and Perfluorooctanesulfonate in Human Serum by LC/MS. Ithaca, NY: Advanced Bioanalytical Services Inc; August 1997.
15. Anderson DJ, Mulvana DE. Analytical Report for the Determination of Perfluorooctanoate and Perfluorooctanesulfonate in Human Serum by LC/MS. Ithaca, NY: Advanced Bioanalytical Services Inc; September 1997.
16. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-349.
17. SAS Institute, Inc. SAS Users Guide: Statistics. Version 6. Cary, NC: SAS Institute, Inc; 1990.
18. Davern TJ, Scharschmidt BF. Biochemical liver tests. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Gastrointestinal and Liver Disease, 6th ed. Philadelphia, PA: W.B. Saunders Co.; 1993: 1112-1122.
19. Lewis JA. Illustrated Guide to Diagnostic Tests. Springhouse, PA: Springhouse Corp; 1994:100-107, 194-207.
20. Friedman LS. Liver, biliary tract and pancreas. In: Tierney LM, McPhee SJ, Papadakis WA, eds. Medical Diagnosis and Treatment, 37th ed. Stamford, CT: Appleton and Lange; 1998:628-630.
21. Fu PC. Lipids, lipoproteins, and apolipoproteins. In: Howanitz JH, Howanitz PJ, eds. Laboratory Medicine: Test Selection and Interpretation. New York: Churchill Livingstone Inc; 1991:173-198.
22. Wolf PL. Liver function. In: Howanitz JH, Howanitz PJ, eds. Laboratory Medicine: Test Selection and Interpretation. New York: Churchill Livingstone Inc; 1991:67-84.
23. Lidofsky S, Scharschmidt BF. Jaundice. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Gastrointestinal and Liver Disease, 6th ed. Philadelphia: W.B. Saunders Co; 1998:220-224.
24. Olsen GW, Kusch GD, Stafford BA, Gudmundsen SL, Currier MF. The positive known association design: a quality assurance method for occupational health surveillance data. J Occup Med. 1991;33: 998-1000.
25. Burns CJ, Boswell JM, Olsen GW. Liver enzyme activity and body mass index. J Occup Environ Med. 1997;38:1248-1252.